Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KASL clinical practice guidelines: management of chronic hepatitis B

Clinical and Molecular Hepatology (2016) Vol. 22, Iss. 1, pp. 18-75
Open Access | Times Cited: 160

Showing 1-25 of 160 citing articles:

2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
KLCA Korean Liver Cancer Association, NCC National Cancer Center
Gut and Liver (2019) Vol. 13, Iss. 3, pp. 227-299
Open Access | Times Cited: 349
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
Gi‐Ae Kim, Young‐Suk Lim, Seungbong Han, et al.
Gut (2017) Vol. 67, Iss. 5, pp. 945-952
Closed Access | Times Cited: 228
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology (2019) Vol. 20, Iss. 7, pp. 1042-1042
Open Access | Times Cited: 221
KASL clinical practice guidelines for management of chronic hepatitis B

Clinical and Molecular Hepatology (2019) Vol. 25, Iss. 2, pp. 93-159
Open Access | Times Cited: 191
Low‐level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment
Jung Hee Kim, Dong Hyun Sinn, Wonseok Kang, et al.
Hepatology (2016) Vol. 66, Iss. 2, pp. 335-343
Open Access | Times Cited: 175
A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea
Seung Up Kim, Yeon Seok Seo, Han Ah Lee, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 3, pp. 456-464
Closed Access | Times Cited: 156
KASL clinical practice guidelines for management of chronic hepatitis B

Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 2, pp. 276-331
Open Access | Times Cited: 89
Reversal of liver cirrhosis: current evidence and expectations
Young Kul Jung, Hyung Joon Yim
The Korean Journal of Internal Medicine (2017) Vol. 32, Iss. 2, pp. 213-228
Open Access | Times Cited: 133
High risk of clinical events in untreated HBeAg‐negative chronic hepatitis B patients with high viral load and no significant ALT elevation
Gwang Hyeon Choi, Gi‐Ae Kim, Jonggi Choi, et al.
Alimentary Pharmacology & Therapeutics (2019) Vol. 50, Iss. 2, pp. 215-226
Closed Access | Times Cited: 100
Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival
Min Woo Lee, Danbee Kang, Hyo Keun Lim, et al.
European Radiology (2020) Vol. 30, Iss. 4, pp. 2391-2400
Closed Access | Times Cited: 84
Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Myung Ji Goh, Dong Hyun Sinn, Seonwoo Kim, et al.
Hepatology (2019) Vol. 71, Iss. 6, pp. 2023-2032
Closed Access | Times Cited: 81
S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11)
Markus Cornberg, Lisa Sandmann, Ulrike Protzer, et al.
Zeitschrift für Gastroenterologie (2021) Vol. 59, Iss. 07, pp. 691-776
Open Access | Times Cited: 73
Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus
Myung Han Hyun, Young‐Sun Lee, Ji Hoon Kim, et al.
Alimentary Pharmacology & Therapeutics (2017) Vol. 45, Iss. 12, pp. 1493-1505
Open Access | Times Cited: 73
Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma
Sang‐Hyun Kang, Shin Hwang, Young Joo Lee, et al.
Journal of Hepato-Biliary-Pancreatic Sciences (2018) Vol. 25, Iss. 4, pp. 240-248
Closed Access | Times Cited: 62
Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir
Jung Hwan Yu, Young Ju Suh, Young‐Joo Jin, et al.
European Journal of Gastroenterology & Hepatology (2019) Vol. 31, Iss. 7, pp. 865-872
Closed Access | Times Cited: 59
The epidemiology of hepatitis B virus infection in Korea
Sun Young Yim, Ji Hoon Kim
The Korean Journal of Internal Medicine (2019) Vol. 34, Iss. 5, pp. 945-953
Open Access | Times Cited: 59
Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection
Sun Hong Yoo, Ji Yoon Kim, Young‐Suk Lim, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 939-946
Closed Access | Times Cited: 34
Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
Won Sohn, Ju‐Yeon Cho, Ji Hoon Kim, et al.
Clinical and Molecular Hepatology (2017) Vol. 23, Iss. 2, pp. 170-178
Open Access | Times Cited: 59
Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis
Young Eun Chon, Jun Yong Park, Sung-Min Myoung, et al.
The American Journal of Gastroenterology (2017) Vol. 112, Iss. 6, pp. 882-891
Closed Access | Times Cited: 53
Non‐invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low‐level viremia
Namyoung Paik, Dong Hyun Sinn, Ji Hae Lee, et al.
Liver International (2017) Vol. 38, Iss. 1, pp. 68-75
Closed Access | Times Cited: 51
The risk of hepatocellular carcinoma among chronic hepatitis B virus‐infected patients outside current treatment criteria
Dong Hyun Sinn, Sung Eun Kim, Beom Kyung Kim, et al.
Journal of Viral Hepatitis (2019) Vol. 26, Iss. 12, pp. 1465-1472
Closed Access | Times Cited: 51
Longterm prognosis of combined hepatocellular carcinoma‐cholangiocarcinoma following liver transplantation and resection
Dong‐Hwan Jung, Shin Hwang, Gi‐Won Song, et al.
Liver Transplantation (2016) Vol. 23, Iss. 3, pp. 330-341
Open Access | Times Cited: 50
Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology
Dong‐Hwan Jung, Shin Hwang, Young Joo Lee, et al.
Annals of Surgery (2017) Vol. 269, Iss. 3, pp. 511-519
Closed Access | Times Cited: 45
Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma
Shin Hwang, Gi‐Won Song, Young Joo Lee, et al.
Journal of Gastrointestinal Surgery (2016) Vol. 20, Iss. 11, pp. 1807-1820
Closed Access | Times Cited: 41
Validation of PAGE‐B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir
Mi Na Kim, Seong Gyu Hwang, Kyu Sung Rim, et al.
Liver International (2017) Vol. 37, Iss. 12, pp. 1788-1795
Closed Access | Times Cited: 41
Page 1 - Next Page

Scroll to top